<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="/resources/stylesheets/content.css">
	<link rel="stylesheet" href="/resources/stylesheets/print.css">
	<link rel="stylesheet" href="/resources/stylesheets/font-awesome.css">

	<!-- Basic Page Needs
  ================================================== -->
    <script src="/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Blood</title>
	<meta name="description" content="Course Notes for Blood">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>

	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="/references/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/blood/search.html">
	<div><input type="text" value="Search Blood" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/blood">Blood</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/blood/search.html">
	<div style="float: left;"><input type="text" value="Search Blood" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

        <div class="course-toc">
            <div class="course-index">
                <a href="http://www.schulichnotes.com/blood">Blood</a>
            </div>
            <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Tuesday, October 15</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/15/intro-blood-hemoglobin.html">Introduction to Blood and Hemoglobin</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/15/normal-hematopoiesis.html">Normal Hematopoiesis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/15/red-cell-indices-abnormalities.html">Red Cell Indices and Abnormalities</a></li></ul>
		<li class="day">Wednesday, October 16</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/16/iron-metabolism.html">Iron Metabolism</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/16/folate-cobalamin.html">Folate &amp; Cobalamin</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/16/pyridoxine-homocysteine.html">Pyridoxin &amp; Homocysteine</a></li></ul>
		<li class="day">Thursday, October 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/17/microcytic-anemias.html">Microcytic Anemias</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/17/normocytic-anemias.html">Normocytic Anemias</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/17/hemolytic-anemias.html">Hemolytic Anemias</a></li></ul>
		<li class="day">Friday, October 18</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/18/sickle-cell-hemoglobinopathies.html">Sickle Cell Disease &amp; Hemoglobinopathies</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/18/macrocytic-anemias.html">Macrocytic Anemias</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/18/pharmacological-treatment-anemias.html">Phamacological Treatment of Anemias</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/18/week-1-wrap-up.html">Week 1 Wrap-up &amp; Case Discussion</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Monday, October 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/21/principles-blood-transfusion.html">Principles of Blood Transfusion</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/21/blood-delivery-canada.html">Blood Delivery System in Canada</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/21/approach-thrombocytopenia.html">Approach to Thrombocytopenia</a></li></ul>
		<li class="day">Tuesday, October 22</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/22/normal-platelet-function.html">Normal Platelet Function</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/22/introduction-hemostasis.html">Introduction to Hemostasis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/22/approach-coagulopathy-adults.html">Approach to Adult Coagulopathies</a></li></ul>
		<li class="day">Wednesday, October 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/23/approach-coagulopathy-pediatric.html">Approach to Pediatric Coagulopathies</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/23/topics-pediatric-hematology-1.html">Topics in Pediatric Hematology 1</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/23/topics-pediatric-hematology-2.html">Topics in Pediatric Hematology 2</a></li></ul>
		<li class="day">Thursday, October 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/24/imaging-venous-thrombosis.html">Imaging for Venous Thrombosis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/24/pharmacology-anticoagulation-1.html">Pharmacology of Anticoagulant Therapy 1</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/24/pharmacology-anticoagulation-2.html">Pharmacology of Anticoagulant Therapy 2</a></li></ul>
		<li class="day">Friday, October 25</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/25/surgical-approach-venous-disease.html">Surgical Approach to Venous Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/25/week-2-wrap-up.html">Week 1 Wrap-up &amp; Case Discussion</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, October 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/28/practical-approach-dvt-pe.html">Practical Approach to Medical Management of DVT/PE</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/28/introduction-core-oncology-what-is-cancer.html">Introduction to Oncology: What is Cancer?</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/28/introduction-core-oncology-is-it-cancer.html">Introduction to Oncology: Is it Cancer?</a></li></ul>
		<li class="day">Tuesday, October 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/29/benign-disorders-white-blood-cells.html">Benign Disorders of White Blood Cells</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/29/myeloproliferative-neoplasms.html">Myeloproliferative Neoplasms</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/29/leukemias.html">Leukemias</a></li></ul>
		<li class="day">Wednesday, October 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/30/lymph-node-flow-cytometry.html">Basics of Lymph Node Flow Cytometry</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/30/lymphoma-classification-hodgkin-lymphoma.html">Lymphoma Classification &amp; Hodgkin Lymphoma</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/30/non-hodgkin-lymphoma.html">Non-Hodgkin Lymphoma</a></li></ul>
		<li class="day">Thursday, October 31</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/31/anemia-pediatric-small-group.html">Anemia Pediatric Small Group</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/10/31/lumps-bumps-family-practice.html">Lumps &amp; Bumps in the Practitioner's Office</a></li></ul>
		<li class="day">Friday, November 1</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/01/multiple-myeloma.html">Multiple Myeloma</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/01/week-3-wrap-up.html">Week 3 Wrap-up &amp; Case Discussion</a></li></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, November 4</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/04/clinical-approach-lymphomas.html">Clinical Approach to the Lymphomas</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/04/lymphadenopathy-lymphoid-malignancies-tutorial.html">Lymphadenopathy &amp; Lymphoid Malignancies Tutorial</a></li></ul>
		<li class="day">Tuesday, November 5</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/05/targeted-therapies-oncology.html">Targeted Therapies in Oncology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/05/pharmacology-antineoplastic-agents-1.html">Pharmacology of Antineoplastic Agents 1</a></li><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/05/pharmacology-antineoplastic-agents-2.html">Pharmacology of Antineoplastic Agents 2</a></li></ul>
		<li class="day">Wednesday, November 6</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/blood/2013/11/06/block-exam-review.html">End of Block Exam Review</a></li></ul>
	</ul>
</nav>
        </div>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Introduction to Blood and Hemoglobin</h1></div>
                <info datetime="2013-10-15">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Tuesday, October 15, 2013</span>
                </info>
                <div class="body"><p><img class="right" src="/images/cnum1__l.png" /></p>

<ul>
  <li>Blood has several components. </li>
  <li>When centrifuged, these layers are split by density. In order from least dense to most dense, we have:
    <ol>
      <li><em>Plasma</em></li>
      <li><strong>Buffy Coat</strong> → WBCs + platelets.</li>
      <li><em>Red Blood Cells</em> → RBCs.</li>
    </ol>
  </li>
  <li>The <strong>hematocrit</strong> (Hct or Ht), is defined as:</li>
</ul>

<script type="math/tex; mode=display">Hct = \frac{\text{height of RBCs}}{\text{height of blood column}} \times 100\%</script>

<ul>
  <li>This is the relative amount of your blood that is comprised of red blood cells.</li>
  <li>Typical values are from <em>40-45%</em>.</li>
</ul>

<blockquote>
  <p>####<strong>Important</strong>
- <strong>Hematocrit</strong> is defined as:</p>

  <script type="math/tex; mode=display">Hct = \frac{\text{height of RBCs}}{\text{height of blood column}} \times 100\%</script>

  <ul>
    <li>Normally ranges from 40-45%.</li>
  </ul>
</blockquote>

<h2 id="constituents-of-blood"><strong>Constituents of Blood</strong></h2>
<ul>
  <li><strong>Cellular Components</strong>:
    <ul>
      <li>RBCs, WBCs, thrombocytes (aka platelets).</li>
    </ul>
  </li>
  <li><strong>Plasma/Fluid</strong>:
    <ul>
      <li>H<sub>2</sub>O, proteins, electrolytes, glucose, fat, minerals, etc.</li>
      <li>Of the proteins, it’s important to note <em>albumin</em>, and <em>clotting factors</em>.</li>
    </ul>
  </li>
  <li><strong>Serum</strong> = <em>plasma WITHOUT clotting factors</em>.</li>
</ul>

<h2 id="diseases-of-the-blood"><strong>Diseases of the Blood</strong></h2>
<ul>
  <li>You can have diseases where you have <i>too little</i> of a blood component, or <i>too much</i> of a blood component.</li>
</ul>

<p>####<strong>Too Little</strong>
- If you have too little of ‘x’, then you have reduced, absent, or dysfunctional behaviour.</p>

<blockquote>
  <p>####<strong>Consequences of ↓ Blood Components</strong></p>

  <table>
    <thead>
      <tr>
        <th style="text-align: left">Factor</th>
        <th style="text-align: left">Result</th>
        <th style="text-align: left">Symptoms</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">RBCs</td>
        <td style="text-align: left"><em>Anemia</em></td>
        <td style="text-align: left">fatigue</td>
      </tr>
      <tr>
        <td style="text-align: left">WBCs</td>
        <td style="text-align: left"><em>Leukopenia</em></td>
        <td style="text-align: left">infection</td>
      </tr>
      <tr>
        <td style="text-align: left">Thrombocytes</td>
        <td style="text-align: left"><em>Thrombocytopenia</em></td>
        <td style="text-align: left">bleeding</td>
      </tr>
      <tr>
        <td style="text-align: left">Clotting Factors</td>
        <td style="text-align: left"><em>Hemophilia</em></td>
        <td style="text-align: left">bleeding</td>
      </tr>
    </tbody>
  </table>
</blockquote>

<p>####<strong>Too Much</strong>
- When you have too much of ‘x’, it could either be a normal physiological response to a stimulus, or an abnormal proliferation (eg. cancer).</p>

<blockquote>
  <p>####<strong>Consequences of ↑ Blood Components</strong></p>

  <table>
    <thead>
      <tr>
        <th style="text-align: left">Factor</th>
        <th style="text-align: left">Result</th>
        <th style="text-align: left">Physiological Stimulus</th>
        <th style="text-align: left">Abnormal Proliferation</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">RBCs</td>
        <td style="text-align: left"><em>Erythrocytosis</em></td>
        <td style="text-align: left">Hypoxia</td>
        <td style="text-align: left"><em>Polycythemia Rubra Vera</em></td>
      </tr>
      <tr>
        <td style="text-align: left">WBCs</td>
        <td style="text-align: left"><em>Leukocytosis</em></td>
        <td style="text-align: left">Infection</td>
        <td style="text-align: left"><em>Leukemia</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Thrombocytes</td>
        <td style="text-align: left"><em>Thrombocytosis</em></td>
        <td style="text-align: left">Inflammatory Response</td>
        <td style="text-align: left"><em>Essential Thrombocytosis</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Clotting Factors</td>
        <td style="text-align: left">Hypercoagulable States</td>
        <td style="text-align: left"> </td>
        <td style="text-align: left"> </td>
      </tr>
    </tbody>
  </table>
</blockquote>

<h1 id="hematopoiesis">Hematopoiesis</h1>
<hr />

<h2 id="location-of-hematopoiesis"><strong>Location of Hematopoiesis</strong></h2>

<ul>
  <li><strong>Hematopoiesis</strong> is the formation of blood components.</li>
  <li><em>In utero</em>, the <strong>yolk sac</strong> is the first site of hematopoiesis.</li>
  <li>At around <em>5-6 weeks gestation</em>, the <strong>liver and spleen</strong> become the primary source of hematopoiesis.
    <ul>
      <li>They remain as such until around the 3<sup>rd</sup> trimester.</li>
    </ul>
  </li>
  <li>The <strong>bone marrow</strong> starts becoming active at around <em>3 months</em>, and becomes the major source of hematopoiesis from <em>5-6 months onward</em>.
    <ul>
      <li>Conventionally, it is thought that the bone marrow becomes the sole source of hematopoiesis after this point, but in some diseases where the bone marrow is damaged, you can actually see blood production in the spleen and liver again!</li>
      <li>The idea is that the stem cells can actually migrate to these previous sources of hematopoiesis.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <p>####<strong>Important</strong>
- Will be on the exam!
- The <strong>yolk sac</strong> is the <em>first site of hematopoiesis</em>.
- The <strong>liver and spleen</strong> become the main source of hematopoiesis at <em>5-6 weeks gestation</em>.
- The <strong>bone marrow</strong> starts at around <em>3 months</em>, and becomes the major source of hematopoiesis by <em>7 months</em>.</p>
</blockquote>

<p><img src="/images/408ufk0y.png" /></p>

<h2 id="regulation-of-hematopoiesis"><strong>Regulation of Hematopoiesis</strong></h2>
<ul>
  <li>The production of blood components has a high degree of turnover → approximately 1 trillion cells/day.
    <ul>
      <li>Because of this high turnover, the blood is at risk for dysfunctional growth regulation, which will be seen later in this block.</li>
    </ul>
  </li>
  <li>Production is responsive to <em>cytokines</em>, which can increase the production of certain cell lineages.
    <ul>
      <li><em>Hypoxia</em> leads to the release of the cytokine <em>EPO</em> (Erythropoietin), which <em>↑RBCs</em>.</li>
      <li><em>Infection</em> leads to the release of <em>GCSF</em> (Granulocyte Colony Stimulating Factor), which <em>↑neutrophils</em>.</li>
      <li><em>Hemorrhage</em> leads to the release of <em>thrombopoietin</em>, which <em>↑platelets</em>.</li>
    </ul>
  </li>
</ul>

<h2 id="the-process-of-hematopoiesis"><strong>The Process of Hematopoiesis</strong></h2>
<ul>
  <li>Hematopoiesis starts with HSCs.</li>
  <li><strong>HSC</strong> → <em>Hematopoietic Stem Cell</em>.
    <ul>
      <li>These are <i>blood cell progenitors</i>, and they exist in a small pool (~0.1% of the bone marrow, ~0.01% of the peripheral blood).</li>
      <li>These are <em>pluripotent</em> → HSCs generate all blood cells (RBCs, WBCs, platelets).</li>
    </ul>
  </li>
  <li><strong>Important</strong> → To be a stem cell, <em>2 features</em> must be satisfied:
    <ol>
      <li><em>Pluripotent</em> → can generate multiple cell lineages.</li>
      <li><em>Capacity for self-renewal</em> → ie. they’re ‘immortal’.</li>
    </ol>
  </li>
  <li>HSCs are a quiescent pool of cells → only ~5% are dividing at any point in time.</li>
  <li>To ‘self renew’, these cells are maintained by <strong>asymmetric division</strong>:</li>
</ul>

<blockquote>
  <p>####<strong>Stem Cell Criteria</strong>
- Will be on the exam!
- To be a stem cell, <em>2 features</em> must be satisfied:
	1. <strong>Pluripotent</strong> → can generate multiple cell lineages.
	2. <strong>Capacity for self-renewal</strong> → ie. they’re ‘immortal’.</p>
</blockquote>

<p><img class="right" src="/images/5tioyxln.png" /></p>

<ul>
  <li>It’s important to differentiate <i>pluripotent</i> hematopoietic stem cells, from <i>totipotent</i> embryonic stem cells:
    <ol>
      <li><strong>Totipotent</strong> (embryonic) → can regenerate the entire organism. </li>
      <li><strong>Pluripotent</strong> (eg. HSCs) → can regenerate multiple lineages. Can’t regenerate everything, but they can regenerate a lot.
        <ul>
          <li>Adult tissues can be induced to become pluripotent stems cells (Shinya Yamanaka’s ground-breaking research on iPSCs). </li>
        </ul>
      </li>
    </ol>
  </li>
  <li>HSC Maturation proceeds in the following phases:
    <ul>
      <li><em>Stem cell</em> → pluripotent, quiescent.</li>
      <li><em>Colony forming unit</em> (CFU) → high proliferative rate, multilineage potential, limited self renewal.</li>
      <li><em>Committed CFU</em> → high proliferative rate, <em>lineage specific</em></li>
    </ul>
  </li>
  <li><em>Growth regulation</em> typically occurs at the <strong>committed CFU stage</strong> (this is where EPO acts, for instance).
    <ul>
      <li><strong>CFU</strong> = <em>colony forming unit</em>.</li>
      <li>At the committed CFU stage, the HSC has already ‘committed’ itself to a single cell lineage.</li>
      <li>It makes sense for growth regulation to occur at this stage, since you don’t want amplification of non-specific cells!</li>
    </ul>
  </li>
  <li>As differentiation progresses, cell-type specificity increases:
    <ul>
      <li>HSC → lymphoid progenitor → lymphocytes.</li>
      <li>HSC → myeloid progenitor → platelets, red cells, monocytes.</li>
    </ul>
  </li>
</ul>

<p><img src="/images/7d5gqdd4.png" /></p>

<p>####<strong>Clinical Correlates of Stem Cell Dysfunction</strong>
- <em>Loss of HSCs</em> → <strong>aplastic anemia</strong>, where you have a loss of <i>all cell lineages</i>. Often as a result of severe radiation.
- <em>Loss of committed CFUs</em> → eg. <strong>pure red cell aplasia</strong> (loss of RBCs only), or <strong>chronic neutropenia</strong> (rare).
- Problems with stem cells are often treated with <em>stem cell transplantation</em> (ie. a bone marrow transplant).
- If you have malignant/clonal expansion of HSCs or differentiated committed CFUs, you end up with blood cancers.
- Cancer proliferation can be <em>monoclonal</em> or <em>polyclonal</em>:
	- <em>Monoclonal</em> = cancer arose from one ‘clone’ only.
	- <em>Polyclonal</em> = cancer has arisen from multiple ‘clones’, which makes it harder to treat. Polyclonal cancers typically arise due to accelerated rates of mutagenesis.</p>

<h1 id="red-blood-cells">Red Blood Cells</h1>
<hr />

<ul>
  <li>Red blood cells are <em>biconcave discs</em>. This structure has a number of advantages:
    <ol>
      <li>It maximizes flexibility, which is important in small vessels.</li>
      <li>It maximizes surface area for gas exchange.</li>
      <li>It maximizes laminar flow at high shear.</li>
    </ol>
  </li>
  <li>RBCs function to <em>transfer O<sub>2</sub>, CO<sub>2</sub>, and NO</em>.
    <ul>
      <li><em>NO</em> → Nitric Oxide, a vasodilator.</li>
    </ul>
  </li>
  <li>RBCs also have a postulated role as an oxygen sensor:
    <ul>
      <li>The theory (still hasn’t been proven) is that RBCs deoxygenate, they travel to regions with low circulating O<sub>2</sub>, where they can release NO and cause vasodilation.</li>
      <li>This increases blood flow to areas with poor oxygenation.</li>
    </ul>
  </li>
</ul>

<h2 id="erythropoiesis"><strong>Erythropoiesis</strong></h2>
<ul>
  <li>The following numbers are important to remember:
    <ul>
      <li>The <em>normal RBC lifespan</em> is <strong>120 days</strong>.</li>
      <li>The <em>daily replacement rate</em> of RBCs is about <strong>1%</strong> of the RBC pool.</li>
    </ul>
  </li>
  <li>Young RBCs are called <em>reticulocytes</em>, and they have key distinguishing features that will be discussed later.</li>
  <li>Production of RBCs is stimulated when there is <em>poor tissue oxygenation.</em>
    <ul>
      <li>Oxygen delivery can be assessed as <script type="math/tex">\text{Oxygen Delivery} = \text{Cardiac Output} \times C_aO_2</script>, where <script type="math/tex">C_aO_2</script> is the arterial oxygen concentration. This is fairly intuitive.</li>
      <li>The <script type="math/tex">C_aO_2</script> can be calculated by looking at (1) the amount of hemoglobin, (2) the amount of oxygen that can be carried by each unit of hemoglobin, and (3) how saturated each hemoglobin molecule is.</li>
      <li>In other words, <script type="math/tex">C_aO_2 = \text{Oxygen Saturation %} \times 1.34 \times (Hb)</script>, where <strong>1.34 mL/g</strong> is the amount of oxygen that can be carried by 1 gram of Hb.</li>
    </ul>
  </li>
  <li><strong>Erythropoietin</strong> is the growth factor that <em>stimulates RBC production</em>.
    <ul>
      <li>It’s produced by <em>peritubular cells in the kidney</em> → so if you have renal failure, you’ll produce fewer RBCs.
        <ul>
          <li>These patients will often need supplemental exogenous EPO.</li>
          <li>This is important to know → it was tested last year.</li>
        </ul>
      </li>
      <li>As mentioned before, it primarily acts on committed-CFUs, by stimulating growth, and preventing apoptosis.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <p>####<strong>Important</strong>
- <strong>Erythropoietin</strong> is the growth factor that <em>stimulates RBC production</em>.
- <strong>It’s produced by peritubular cells in the kidney</strong>.</p>
</blockquote>

<ul>
  <li><strong>Hemoglobin</strong> is the protein that carries oxygen in the RBC.
    <ul>
      <li>It comprises 90% of the RBC mass, and is a tetramer (2 α units, 2 β units).</li>
      <li><em>It requires iron</em>, which is contained in a heme porphyrin ring.</li>
      <li>There are <em>2 α-globin genes located on chromosome 16</em>, hence we have <em>4 α-globin genes per diploid cell.</em></li>
      <li>The <em>β-globin family of genes</em>, of which there is γ, β, and δ isoforms, is located on chromosome 11.
        <ul>
          <li><strong>Fetal Hb</strong> → <script type="math/tex">\alpha_2\gamma_2</script> (HbF).</li>
          <li><strong>Adult Hb</strong> → <script type="math/tex">\alpha_2\beta_2</script> (HbA).</li>
          <li><strong>HbA<sub>2</sub></strong> → <script type="math/tex">\alpha_2\delta_2</script> (HbA<sub>2</sub>).</li>
        </ul>
      </li>
      <li>HbA<sub>2</sub> is a minor hemoglobin, which is important in patients with beta-thalassemias, because these hemoglobin variants (HbF, HbA<sub>2</sub>) can compensate for reduced adult hemoglobin.</li>
    </ul>
  </li>
  <li><strong>Low Hemoglobin</strong> → <em>Anemia</em>.</li>
  <li><strong>Low Globin</strong> → <em>Thalassemia</em>.</li>
  <li><strong>Low Iron</strong> → <em>Iron Deficiency Anemia</em>.</li>
  <li><strong>Mutation in β-globin gene</strong> (6th codon, glu → val) → <em>Sickle Cell Anemia</em>.
    <ul>
      <li>You have to remember the <em>G6V mutation</em> for sickle cell.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <p>####<strong>Remember</strong>
- <strong>Sickle cell anemia</strong> is caused by a homozygous mutation in the <em>6th codon</em> of the <em>β-globin gene</em>, from <em>glutamic acid to valine.</em></p>
</blockquote>

<h1 id="white-blood-cells">White Blood Cells</h1>
<hr />

<ul>
  <li>Comprise 1% of the cellular component of blood.</li>
  <li>Can be broadly classified into <em>granulocytes</em> (with granules), and <em>agranulocytes</em> (without granules):
    <ul>
      <li><strong>Granulocytes</strong>:
        <ul>
          <li><em>Basophils</em>.</li>
          <li><em>Neutrophils</em>.</li>
          <li><em>Eosinophils</em>.</li>
        </ul>
      </li>
      <li><strong>Agranulocytes</strong>:
        <ul>
          <li><em>Lymphocytes</em>.</li>
          <li><em>Monocytes</em>.</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

<h1 id="platelets">Platelets</h1>
<hr />

<p><img class="right" src="/images/0v25wi3m.png" /></p>

<ul>
  <li>The smallest cellular component of blood, they circulate in an <em>inactive form</em>.</li>
  <li>These are <em>not actually a cell</em> → they’re actually fragments of cytoplasm from a larger cell called a <strong>megakaryocyte</strong>.</li>
  <li>These circulating inactive platelets are <em>activated upon contact with basement membrane or collagen</em>. 
    <ul>
      <li>In other words, when the endothelial lining of the blood vessel has been breached.</li>
    </ul>
  </li>
  <li>When activated, platelets form a <em>1° hemostatic plug</em>, which plugs the breach in the endothelial lining.
    <ul>
      <li>They also initiate the <em>coagulation cascade</em>, which will be discussed in gory detail later on.</li>
    </ul>
  </li>
  <li><strong>Thrombopoietin</strong> is the growth factor that stimulates <em>platelet production</em>.
    <ul>
      <li>It’s produced in the <em>liver</em>.</li>
    </ul>
  </li>
  <li>Platelets have a <em>7-10 day lifespan</em>.</li>
</ul>

<blockquote>
  <p>####<strong>Important</strong>
- <strong>Thrombopoietin</strong> is the growth factor that <em>stimulates platelet production</em>.
- <strong>It’s produced by the liver</strong>.</p>
</blockquote>

<h1 id="blood-during-pregnancy">Blood during Pregnancy</h1>
<hr />

<ul>
  <li>The <em>plasma volume</em> increases by <em>40-60%</em>.</li>
  <li>The <em>red cell mass</em> increases by <em>20-50%</em>.</li>
  <li>In other words, even though you have more RBCs when you’re pregnant, they’re <i>relatively</i> diluted.</li>
  <li>Hence we have <strong>hemodilution</strong> during pregnancy → the hematocrit falls.
    <ul>
      <li>It’s hypothesized that this hemodilution aims to ↓ viscosity, and ↑ perfusion to the fetus.</li>
    </ul>
  </li>
  <li><em>WBCs increase during pregnancy, but normalize post-partum</em>.</li>
  <li><em>Platelet counts remain unchanged.</em></li>
  <li>Coagulation factors increase, but there’s no change in coagulation tests.</li>
  <li>In summary, the major change during pregnancy is a <strong>physiological anemia</strong> due to a greater increase in plasma than in red cell mass.</li>
</ul>

<blockquote>
  <p>####<strong>Remember</strong>
- The major change in pregnancy is a <em>physiological anemia</em> due to a greater increase in plasma than in red cell mass.
- There’s always a question on the exam related to this.</p>
</blockquote>

<h1 id="the-plasma-component">The Plasma Component</h1>
<hr />

<ul>
  <li>Plasma accounts for around 55% of the blood. Of this, 95% if water.</li>
  <li>The rest is <em>protein</em>. They key proteins are:
    <ol>
      <li><strong>Albumin</strong> → maintains colloid oncotic pressure.</li>
      <li><strong>γ-globulins</strong> → antibodies.</li>
      <li><strong>Clotting factors</strong>.</li>
    </ol>
  </li>
  <li>Loss of these proteins has clinical correlates:
    <ol>
      <li><em>Low albumin</em> → <em>nephrotic syndrome</em>.</li>
      <li><em>Low immunoglobulins</em> → <em>immunodeficiency</em>.</li>
      <li><em>Low clotting factors</em> → <em>hemophilia</em>.</li>
    </ol>
  </li>
</ul>

<h1 id="blood-tests">Blood Tests</h1>
<hr />

<ul>
  <li>The main blood test is the <strong>Complete Blood Count</strong> (CBC), which may or may not include a differential (which will show counts for different subtypes of white cells).</li>
  <li><em>What do you get in a CBC?</em>
  <img class="right" src="/images/6zqjf6xu.png" />
    <ul>
      <li><strong>Measured Values</strong>:
        <ol>
          <li><em>White Cell Count</em> → the number of WBCs (will include counts for specific types in a CBC-D).</li>
          <li><em>Hb Concentration</em> → measured in g/L.</li>
          <li><em>RBC count</em>.</li>
          <li><em>Mean Cell Volume (MCV)</em> → the mean RBC volume.</li>
          <li><em>Red Cell Distribution Width (RDW)</em> → the ‘width’ of the distribution of RBC sizes.
            <ul>
              <li>A large RDW is suggestive of a large heterogeneity in RBC sizes.</li>
              <li>A small RDW is suggestive of more homogeneity.</li>
            </ul>
          </li>
          <li><em>Platelet Counts</em>.</li>
        </ol>
      </li>
      <li><strong>Calculated Values</strong>;
        <ol>
          <li><em>Hematocrit (Hct)</em> = <script type="math/tex">RBC \times MCV</script>. This makes sense, it’s the number of red blood cells, times their average volume.</li>
          <li><em>Mean Cell Hb (MCH)</em> = <script type="math/tex">Hb/RBC</script>. This is also obvious.</li>
          <li><em>Mean Cell Hb Concentration (MCHC)</em> = <script type="math/tex">Hb/(RBC \times MCV)</script>, which is the same as <script type="math/tex">Hb/Hct</script>.</li>
        </ol>
      </li>
    </ul>
  </li>
  <li>In practice, we really only look at the measured values, not the calculated ones.</li>
  <li><em>The MCV is particularly important because it’s used to classify anemias</em>:
    <ul>
      <li><strong>Microcytic Anemia</strong> = Anemia + low MCV.</li>
      <li><strong>Normocytic Anemia</strong> = Anemia + normal MCV.</li>
      <li><strong>Macrocytic Anemia</strong> = Anemia + high MCV.</li>
    </ul>
  </li>
</ul>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/blood/2013/10/15/normal-hematopoiesis.html">Normal Hematopoiesis <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/blood/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="/resources/stylesheets/search.css">	
<script src="/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>